242 related articles for article (PubMed ID: 31180562)
1. Reductions in gut microbiota‑derived metabolite trimethylamine N‑oxide in the circulation may ameliorate myocardial infarction‑induced heart failure in rats, possibly by inhibiting interleukin‑8 secretion.
Li X; Sun Y; Zhang X; Wang J
Mol Med Rep; 2019 Jul; 20(1):779-786. PubMed ID: 31180562
[TBL] [Abstract][Full Text] [Related]
2. 3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice.
Wang G; Kong B; Shuai W; Fu H; Jiang X; Huang H
J Nutr Biochem; 2020 Apr; 78():108341. PubMed ID: 32004931
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of Circulating Trimethylamine N-Oxide Prevents the Progression of Cardiac and Renal Dysfunction in a Rat Model of Chronic Cardiorenal Syndrome.
Zou D; Li Y; Sun G
Front Pharmacol; 2021; 12():751380. PubMed ID: 34721039
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating trimethylamine N-oxide contributes to endothelial dysfunction in a rat model of chronic kidney disease.
Li T; Gua C; Wu B; Chen Y
Biochem Biophys Res Commun; 2018 Jan; 495(2):2071-2077. PubMed ID: 29247650
[TBL] [Abstract][Full Text] [Related]
5. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity.
Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y
Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145
[TBL] [Abstract][Full Text] [Related]
6. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis.
Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J
J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216
[TBL] [Abstract][Full Text] [Related]
7. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
[TBL] [Abstract][Full Text] [Related]
8. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
[TBL] [Abstract][Full Text] [Related]
9. Heart Failure Disturbs Gut-Blood Barrier and Increases Plasma Trimethylamine, a Toxic Bacterial Metabolite.
Drapala A; Szudzik M; Chabowski D; Mogilnicka I; Jaworska K; Kraszewska K; Samborowska E; Ufnal M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32859047
[TBL] [Abstract][Full Text] [Related]
10. The presence of elevated circulating trimethylamine N-oxide exaggerates postoperative cognitive dysfunction in aged rats.
Meng F; Li N; Li D; Song B; Li L
Behav Brain Res; 2019 Aug; 368():111902. PubMed ID: 30980850
[TBL] [Abstract][Full Text] [Related]
11. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
12. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction.
Chandrashekhar Y; Sen S; Anway R; Shuros A; Anand I
J Am Coll Cardiol; 2004 Jan; 43(2):295-301. PubMed ID: 14736452
[TBL] [Abstract][Full Text] [Related]
13. Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis.
Li Z; Wu Z; Yan J; Liu H; Liu Q; Deng Y; Ou C; Chen M
Lab Invest; 2019 Mar; 99(3):346-357. PubMed ID: 30068915
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice.
Chen K; Zheng X; Feng M; Li D; Zhang H
Front Physiol; 2017; 8():139. PubMed ID: 28377725
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels.
Petrera A; Gassenhuber J; Ruf S; Gunasekaran D; Esser J; Shahinian JH; Hübschle T; Rütten H; Sadowski T; Schilling O
J Transl Med; 2016 May; 14(1):153. PubMed ID: 27246731
[TBL] [Abstract][Full Text] [Related]
16. [Change of short-chain acyl-CoA dehydrogenase in heart failure after myocardial infarction in rats and the intervention of aerobic exercise].
Liao Y; Li Z; Shu Z; Zhong X; Su Y; Ma Z; Liu P; Lu J; Zang L; Pan X; Zhou S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):172-177. PubMed ID: 30827304
[TBL] [Abstract][Full Text] [Related]
17. Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis.
Yuzefpolskaya M; Bohn B; Javaid A; Mondellini GM; Braghieri L; Pinsino A; Onat D; Cagliostro B; Kim A; Takeda K; Naka Y; Farr M; Sayer GT; Uriel N; Nandakumar R; Mohan S; Colombo PC; Demmer RT
Circ Heart Fail; 2021 Jun; 14(6):e007909. PubMed ID: 34129361
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of inflammation by minocycline improves heart failure and depression-like behaviour in rats after myocardial infarction.
Wang HW; Ahmad M; Jadayel R; Najjar F; Lagace D; Leenen FHH
PLoS One; 2019; 14(6):e0217437. PubMed ID: 31233508
[TBL] [Abstract][Full Text] [Related]
19. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.
Organ CL; Otsuka H; Bhushan S; Wang Z; Bradley J; Trivedi R; Polhemus DJ; Tang WH; Wu Y; Hazen SL; Lefer DJ
Circ Heart Fail; 2016 Jan; 9(1):e002314. PubMed ID: 26699388
[TBL] [Abstract][Full Text] [Related]
20. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
